About Bhagirdha
Advancing Agriculture Through Chemistry
ABOUT BCIL
A Legacy of Science and Responsibility
BCIL specialises in the development and manufacture of high-quality agrochemical technicals and intermediates, supported by strong in-house R&D and non-infringing process capabilities. Continuous investment in process innovation, safety, and regulatory compliance has strengthened manufacturing at its Ongole facility, while phased capacity expansion through its wholly owned subsidiary, Bheema Fine Chemicals Pvt. Ltd., positions the Company for future growth.
At BCIL, our chemistry goes beyond molecules; it shapes how we build trust, collaborate responsibly, and create long-term value for agriculture worldwide. Cost-effective, safe, and high-quality process syntheses. Our Strong focus is on off-patent molecules with domestic & global potential. Backward integration enabling quality assurance, cost efficiency & secured supply.
Mission
“To conserve nature’s resources and safeguard the farmers who feed the world by delivering innovative, safe, and sustainable agrochemical solutions.”
Vision
“To deliver safe, reliable, and cost-effective agrochemical solutions through excellence in process synthesis and manufacturing.”
MILESTONES
Milestones That Define Our Legacy
1993
Foundation
Bhagiradha Chemicals & Industries Limited was established, marking the beginning of a science-led agrochemical manufacturing journey.
1994-2000
Early Scale-Up
The Company commissioned its first 300 MT Chlorpyrifos facility, launched its IPO, and commenced commercial production, translating vision into execution.
2001-2005
Capacity Expansion
Production Block-2 was constructed, manufacturing of Triclopyr and Fluroxypyr commenced, and products such as Imidacloprid were added to the portfolio.
2006-2010
Portfolio Diversification
Production Block-3 expanded capacity to 3,250 MT, turnover crossed ₹100 crore, and new products, including Clodinafop Propargyl, Cloquintocet Mexyl, and Thiamethoxam, were launched.
2011-2015
Product Depth & Exports
The portfolio deepened with launches of Azoxystrobin, 2,6-Dichloroaniline, Penoxsulam intermediate, and Diafenthiuron, alongside entry into export markets including the United States.
2016-2020
Group Expansion
BCIL expanded its growth platform through a dedicated Fipronil process line, portfolio expansion, entry into the top 1,000 by market capitalisation, and incorporation of a wholly owned subsidiary.
2021-2025
Looking Ahead
Operations commenced at Bheema Fine Chemicals as the Group crossed ₹500 crore in turnover, with capacity expansion underway to support backward integration and portfolio growth.